HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

S J Kim Selected Research

isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone

7/2013Caspase blockade induces RIP3-mediated programmed necrosis in Toll-like receptor-activated microglia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


S J Kim Research Topics

Disease

58Neoplasms (Cancer)
09/2017 - 01/2000
20Infections
02/2017 - 01/2000
17Breast Neoplasms (Breast Cancer)
01/2014 - 01/2000
14Hepatocellular Carcinoma (Hepatoma)
04/2014 - 12/2000
12Hemorrhage
07/2010 - 01/2000
11Neoplasm Metastasis (Metastasis)
09/2013 - 01/2000
10Lymphoma (Lymphomas)
09/2017 - 06/2001
9Inflammation (Inflammations)
01/2022 - 12/2000
8Chronic Kidney Failure (Chronic Renal Failure)
04/2016 - 01/2000
8Tuberculosis (Tuberculoses)
08/2009 - 06/2000
8Stomach Neoplasms (Stomach Cancer)
02/2006 - 01/2000
8Carcinogenesis
09/2003 - 03/2000
7Body Weight (Weight, Body)
10/2021 - 02/2001
7Necrosis
02/2017 - 07/2000
6Colonic Neoplasms (Colon Cancer)
06/2017 - 03/2000
6Pathologic Constriction (Stenosis)
12/2016 - 09/2006
5Type 2 Diabetes Mellitus (MODY)
12/2017 - 06/2000
5Disease Progression
03/2016 - 09/2001
5Hypoxia (Hypoxemia)
01/2016 - 04/2000
5Hepatitis B
09/2006 - 11/2000
4Chronic Renal Insufficiency
04/2019 - 11/2000
4Pain (Aches)
09/2017 - 12/2000
4Type 1 Diabetes Mellitus (Autoimmune Diabetes)
06/2017 - 11/2000
4Aneurysm (Aneurysms)
09/2016 - 09/2001
4Multiple Myeloma
10/2015 - 11/2010
4Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive)
10/2015 - 02/2000
4Carcinoma (Carcinomatosis)
01/2015 - 01/2000
4Delayed Graft Function
10/2013 - 07/2011
4Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis)
09/2013 - 05/2000
4Stroke (Strokes)
11/2012 - 04/2008
4Liver Cirrhosis (Hepatic Cirrhosis)
09/2006 - 07/2000
4Fibrosis (Cirrhosis)
02/2001 - 01/2000
3Schizophrenia (Dementia Praecox)
06/2018 - 09/2004
3Wounds and Injuries (Trauma)
02/2017 - 08/2000
3Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
04/2016 - 02/2009
3Periodontitis
12/2015 - 12/2013
3Thyroid Neoplasms (Thyroid Cancer)
07/2013 - 01/2000
3Bacterial Infections (Bacterial Infection)
05/2013 - 09/2004
3Seizures (Absence Seizure)
09/2012 - 05/2000
3End Stage Liver Disease
03/2012 - 09/2006
3Chronic Obstructive Pulmonary Disease (COPD)
09/2011 - 11/2001

Drug/Important Bio-Agent (IBA)

14Transforming Growth Factor beta (TGF-beta)IBA
09/2003 - 01/2000
11DNA (Deoxyribonucleic Acid)IBA
01/2015 - 02/2000
11Proteins (Proteins, Gene)FDA Link
07/2013 - 01/2000
9CreatinineIBA
01/2014 - 09/2004
8CytokinesIBA
01/2016 - 06/2001
8Transforming Growth Factor-beta Type II ReceptorIBA
09/2003 - 01/2000
7Biomarkers (Surrogate Marker)IBA
01/2022 - 11/2004
7BilirubinIBA
03/2016 - 10/2004
7Messenger RNA (mRNA)IBA
09/2003 - 01/2000
6Cyclophosphamide (Cytoxan)FDA LinkGeneric
04/2016 - 01/2000
6Paclitaxel (Taxol)FDA LinkGeneric
12/2012 - 11/2005
6ParaffinIBA
02/2006 - 01/2000
5Glucose (Dextrose)FDA LinkGeneric
10/2021 - 06/2000
5Interleukin-8 (Interleukin 8)IBA
02/2017 - 04/2000
5Transforming Growth Factor beta1 (TGF beta 1)IBA
12/2004 - 04/2000
5Cadherins (E-Cadherin)IBA
09/2001 - 09/2000
4Interleukin-6 (Interleukin 6)IBA
01/2022 - 09/2012
4LipopolysaccharidesIBA
12/2018 - 10/2009
4InterferonsIBA
06/2017 - 02/2000
4Doxorubicin (Adriamycin)FDA LinkGeneric
04/2016 - 09/2001
4VaccinesIBA
05/2014 - 05/2002
4AlbuminsIBA
10/2013 - 04/2010
4Pharmaceutical PreparationsIBA
09/2013 - 04/2001
4LigandsIBA
07/2013 - 08/2000
4Transforming Growth Factors (Transforming Growth Factor)IBA
12/2012 - 01/2001
4SteroidsIBA
04/2012 - 09/2006
4Docetaxel (Taxotere)FDA Link
01/2012 - 03/2005
4Hemoglobins (Hemoglobin)IBA
04/2010 - 11/2001
4Transforming Growth Factor beta Receptors (TGF beta Receptors)IBA
04/2002 - 03/2000
4Matrix Metalloproteinases (MMPs)IBA
09/2001 - 01/2000
3Indicators and Reagents (Reagents)IBA
05/2019 - 01/2008
3Biological ProductsIBA
12/2018 - 01/2001
3Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
10/2018 - 07/2000
3AnthracyclinesIBA
01/2018 - 02/2012
3Histone Deacetylases (Histone Deacetylase)IBA
11/2016 - 02/2001
3Histone Deacetylase InhibitorsIBA
11/2016 - 02/2001
3Immunoglobulin G (IgG)IBA
12/2015 - 04/2000
3HLA Antigens (Human Leukocyte Antigens)IBA
01/2014 - 01/2009
3Progesterone Receptors (Progesterone Receptor)IBA
12/2012 - 02/2011
3Epirubicin (Ellence)FDA LinkGeneric
12/2012 - 02/2011
3Estrogen ReceptorsIBA
12/2012 - 02/2011
3Carrier Proteins (Binding Protein)IBA
12/2012 - 03/2001
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2012 - 04/2000
3Interleukin-10 (Interleukin 10)IBA
09/2012 - 11/2001
3Thiopental (Pentothal)FDA Link
07/2012 - 06/2009
3Tacrolimus (Prograf)FDA LinkGeneric
01/2012 - 09/2004

Therapy/Procedure

28Liver Transplantation
06/2017 - 11/2000
25Therapeutics
06/2017 - 01/2000
21Transplantation
04/2016 - 01/2000
16Kidney Transplantation
04/2016 - 01/2000
15Drug Therapy (Chemotherapy)
01/2018 - 01/2000
12Stents
09/2016 - 12/2000
5Organ Transplantation
01/2018 - 06/2003
4Neoadjuvant Therapy
01/2014 - 09/2001
4Hematopoietic Stem Cell Transplantation
10/2011 - 11/2007
4Ligation
08/2004 - 12/2000
3Islets of Langerhans Transplantation
06/2017 - 09/2010
3Stem Cell Transplantation
06/2016 - 01/2000
3Adjuvant Chemotherapy
02/2012 - 01/2000